Crossref
2024 leucovorin paper retracted, drug pending FDA approval for cerebral folate deficiency
The Brown University Child & Adolescent Psychopharmacology Update · 2026-04 · 28 (4) · 7-7
DOI: 10.1002/cpu.31055 ↗At a glance
Journal article in The Brown University Child & Adolescent Psychopharmacology Update, published online on 2026-03-23. Written by Alison Knopf.
Abstract (original language)
Santrauka nepasiekiama.
Cite
APA
Knopf, A. (2026). 2024 leucovorin paper retracted, drug pending FDA approval for cerebral folate deficiency. The Brown University Child & Adolescent Psychopharmacology Update, 28(4), 7-7. https://doi.org/10.1002/cpu.31055
Vancouver
Knopf A. 2024 leucovorin paper retracted, drug pending FDA approval for cerebral folate deficiency. The Brown University Child & Adolescent Psychopharmacology Update. 2026;28(4):7-7. doi:10.1002/cpu.31055
BibTeX
@article{Knopf2026,
author = {Knopf, Alison},
title = {2024 leucovorin paper retracted, drug pending FDA approval for cerebral folate deficiency},
journal = {The Brown University Child & Adolescent Psychopharmacology Update},
year = {2026},
volume = {28},
number = {4},
pages = {7--7},
doi = {10.1002/cpu.31055}
}
EUVIMED